The case for extending the HPV vaccine is clear and urgent

Source: www.huffingtonpost.co.uk Author: Dr Shaun Griffin Last month the world marked Immunization Week, an opportunity to raise awareness about the importance of routine life-saving immunizations and how they have transformed our approach to public health over the course of centuries. Close the Immunization Gap was this year's theme by the World Health Organisation. Progress towards global vaccination targets for 2015 is far off-track, according to the WHO one in five children still miss out on routine life-saving immunizations that could avert 1.5 million deaths each year from preventable diseases. The immunization gap also extends to gender, age and sexuality. A vaccination programme against the human papillomavirus (HPV) began in 2008 in the UK for girls aged 12-13 to reduce their risk of developing cervical cancer, which is caused by HPV. However, emerging research over the past eight years has found that cancers of the head, mouth, throat, penis and anus can also be caused by strains of the virus. The incidence rate of anal cancer in men who have sex with men (MSM) is increasing. Anal cancer incidence rates in MSM are equivalent to the rates that existed for cervical cancer in women before 1988, when the Government introduced the cervical cancer screening programme. Cancer Research UK (CRUK) estimated incidence rate of anal cancer is 78 per 100,000 per year in HIV-positive MSMs who are on HAART (anti-retroviral treatment), compared with 5 per 100,000 per year in HIV-negative MSMs. Around 5,500 men were diagnosed with oral, penile or anal cancer [...]

HPV links to throat cancer in males

Source: www.thesimmonsvoice.com Author: Emese Nemeth Whether it is your first year or you are returning to college, there are always emails and pamplets about immunizations. While some vaccines are mandatory for public safety and health, vaccines such as Gardasil (also known as Silgard) for the Human Papillomavirus (HPV) are not. While some may argue that it is relatively new vaccine and side effects may be uncertain, the benefits are starting to out-weigh the risks. Gardasil was approved by the Food and Drug Administration (FDA) in 2006 to vaccinate against the four most common strains of HPV: types 6, 11, 16 and 18. Seventy percent of cervical cancer is caused by types 16 and 18. Types 16 and 18 are also known to cause HPV induced cancer of the anus, vulva, vagina and penis. The other two types, 6 and 11 are known to cause ninety percent of genital wart cases. More recently, HPV has been linked to induce throat cancer, specifically, oropharyngeal cancer. The American Society of Clinical Oncology also believes that "the annual occurrence of HPV-related oropharyngeal cancer among men will surpass that of cervical cancer among women by the year 2020." Why throat cancer is more prevalent in men is still unclear, but throat cancer still affects both sexes with 6,700 cases of HPV-positive oropharynx cancers in 2010. While cervical cancer is on the decline due to regular pap smears, throats are only examined due to pain or unusual symptoms. Although Gardasil does not claim to prevent throat [...]

2011-09-23T16:21:46-07:00September, 2011|Oral Cancer News|
Go to Top